Wolters Kluwer Enhances Sentri7 Drug Diversion and Pharmacy Tools to Drive Safer, Patient-Centered Medication Management

Wolters Kluwer Enhances Sentri7 Drug Diversion and Pharmacy Tools to Drive Safer, Patient-Centered Medication Management

(IN BRIEF) Wolters Kluwer Health has announced comprehensive updates to its Sentri7 Drug Diversion and Sentri7 Pharmacy solutions, enhancing medication safety and compliance workflows for healthcare teams. The upgraded tools feature more intuitive user interfaces, improved risk scoring, enhanced documentation, and actionable performance insights to support faster decision-making and better patient care. These enhancements reflect Wolters Kluwer’s ongoing commitment to helping healthcare organizations address medication management challenges, drug diversion, and cost optimization through intelligent, collaborative technology solutions.

(PRESS RELEASE) ALPHEN AAN DEN RIJN, 10-Jun-2025 — /EuropaWire/ — Wolters Kluwer Health has announced significant enhancements to its Sentri7® Drug Diversion and Sentri7® Pharmacy solutions, underscoring its commitment to equipping healthcare organizations with advanced tools that improve medication safety, ensure regulatory compliance, and promote higher-quality patient care. These latest updates introduce patient- and staff-centric workflows, intuitive interfaces, and data-driven insights designed to help clinical teams address critical challenges such as medication management and drug diversion more efficiently.

“Our mission is to help healthcare organizations deliver safer, higher-quality care with solutions that optimize workflows supporting both patient outcomes and compliance,” said Karen Kobelski, Vice President and General Manager of Clinical Surveillance Compliance & Data Solutions at Wolters Kluwer Health. “With our deep expertise in pharmacy, technology, and artificial intelligence, we are empowering customers to respond to challenges like drug diversion, opioid misuse, and cost management with targeted, actionable insights.”

Enhanced Sentri7 Drug Diversion Tools for Risk Mitigation
The redesigned Sentri7 Drug Diversion platform now offers a more intuitive and efficient user experience, helping teams proactively identify and respond to drug diversion threats across care settings.

Among the most impactful updates are:

• Centralized dashboard: A streamlined interface that displays consolidated risk factors and real-time insights, allowing for quicker follow-up and interventions.
• Refined HEAT™ scoring system and trend analysis: Enables faster identification of high-risk individuals with a customizable Watch List to focus resources on critical areas.
• Missing medication reconciliation: Helps nursing teams resolve discrepancies more efficiently by analyzing medication transactions across units, minimizing manual investigation time.

As noted by a pharmacy manager interviewed by KLAS Research in February 2025, “Sentri7 Drug Diversion has a very mature, user-friendly interface. It clearly highlights suspicious activity using the HEAT score, which simplifies our ability to take action.”

Sentri7 Pharmacy Enhancements Enable Patient-Centered Efficiency
The upgraded Sentri7 Pharmacy solution continues to support optimized medication therapy and safety by introducing workflow tools tailored to both patient-specific and population-level surveillance:

• Modernized interface: Built to streamline rounding and medication surveillance for individual patients while also supporting broader pharmacy operations.
• Improved documentation tools: Facilitates more consistent and efficient data entry, strengthening reporting and clinical communication.
• Performance measurement tools: Offers actionable insights into cost savings, care impact, and departmental contributions.

A pharmacy analyst told KLAS Research in April 2025, “Wolters Kluwer is very collaborative and responsive to user feedback. Their commitment to continuous improvement makes Sentri7 Pharmacy Surveillance a valuable and trusted tool in our efforts to enhance patient care.”

These updates reflect Wolters Kluwer’s continued focus on empowering healthcare providers with intelligent technologies that streamline compliance and clinical decision-making, helping teams achieve measurable improvements in safety, quality, and operational efficiency.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Media Contact:

André Rebelo
Director, External Communications
Health
email: andre.rebelo@wolterskluwer.com
Tel: +1 (781) 392-2411

SOURCE: Wolters Kluwer